메뉴 건너뛰기




Volumn 30, Issue 5-6, 1998, Pages 525-538

Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma

Author keywords

CD25; Hodgkin's lymphoma; Immunotoxin; RFT5 SMPT dgA

Indexed keywords

CD30 ANTIGEN; IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR; RICIN A;

EID: 7344268577     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057565     Document Type: Article
Times cited : (60)

References (53)
  • 2
    • 0022553175 scopus 로고
    • Twenty years of MOPP therapy for Hodgkin's lymphoma
    • Longo, I. L., Young, R. C. and Wesley, M. (1986). Twenty years of MOPP therapy for Hodgkin's lymphoma, J. Clin. Oncol., 4, 1295-1306.
    • (1986) J. Clin. Oncol. , vol.4 , pp. 1295-1306
    • Longo, I.L.1    Young, R.C.2    Wesley, M.3
  • 4
    • 0025923704 scopus 로고
    • Anti-My9-blocked ricin: An immunotoxin for selective targeting of acute myeloid leukemia cells
    • Ro, D. C., Griffin, J. D., Belvin, M., Blättler, W. A., Lambert, J. M. and Ritz, J. (1991). Anti-My9-blocked ricin: An immunotoxin for selective targeting of acute myeloid leukemia cells. Blood, 77, 2404-2412.
    • (1991) Blood , vol.77 , pp. 2404-2412
    • Ro, D.C.1    Griffin, J.D.2    Belvin, M.3    Blättler, W.A.4    Lambert, J.M.5    Ritz, J.6
  • 6
    • 0030161641 scopus 로고    scopus 로고
    • Treatment of minimal residual disease in acute myelogenous leukemia (AML): Focus on immunotherapeutic options
    • Simonsson, B. (1996). Treatment of minimal residual disease in acute myelogenous leukemia (AML): focus on immunotherapeutic options. Leukemia, 10 Suppl 2, 44-45.
    • (1996) Leukemia , vol.10 , Issue.2 SUPPL. , pp. 44-45
    • Simonsson, B.1
  • 7
    • 0029118435 scopus 로고
    • Active specific immunotherapy of melanoma
    • Mitchell, M. S. (1995). Active specific immunotherapy of melanoma.Br. Med. Bull., 51 (3), 631-645.
    • (1995) Br. Med. Bull. , vol.51 , Issue.3 , pp. 631-645
    • Mitchell, M.S.1
  • 8
  • 9
    • 0030227736 scopus 로고    scopus 로고
    • Hodgkin's disease. Future treatment strategies: Fact or fiction
    • V. Diehl (ed.)
    • Schnell, R., Barth, S., Diehl, V. and Engert, A. (1996). Hodgkin's disease. Future treatment strategies: fact or fiction. In Baillieres Clinical Haematology, V. Diehl (ed.), pp.573-593.
    • (1996) Baillieres Clinical Haematology , pp. 573-593
    • Schnell, R.1    Barth, S.2    Diehl, V.3    Engert, A.4
  • 10
    • 0021270185 scopus 로고
    • Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's lymphoma
    • Hsu, S. M. and Jaffe, E. S. (1984). Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's lymphoma. Am. J. Clin. Pathol., 82, 29-32.
    • (1984) Am. J. Clin. Pathol. , vol.82 , pp. 29-32
    • Hsu, S.M.1    Jaffe, E.S.2
  • 11
    • 0023635656 scopus 로고
    • Effect of monoclonal antibodies anti-2H9, anti-IRac, and anti-HeFi-1 on the surface antigens of Reed-Sternberg cells
    • Hsu, S. M., Ho, Y. S. and Hsu, P. L. (1987). Effect of monoclonal antibodies anti-2H9, anti-IRac, and anti-HeFi-1 on the surface antigens of Reed-Sternberg cells. J. Nat. Cancer Inst., 79, 1091-1097.
    • (1987) J. Nat. Cancer Inst. , vol.79 , pp. 1091-1097
    • Hsu, S.M.1    Ho, Y.S.2    Hsu, P.L.3
  • 12
    • 0021972684 scopus 로고
    • The expression of the Hodgkin's-disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Sternberg-Reed cells and histocytic malignancies are derived from activated lymphoid cells
    • Stein, H., Mason, D. Y., Gerdes, J., O'Conner, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., Schwarting, R. and Lennert, K. (1985). The expression of the Hodgkin's-disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Sternberg-Reed cells and histocytic malignancies are derived from activated lymphoid cells. Blood, 66, 848-858.
    • (1985) Blood , vol.66 , pp. 848-858
    • Stein, H.1    Mason, D.Y.2    Gerdes, J.3    O'Conner, N.4    Wainscoat, J.5    Pallesen, G.6    Gatter, K.7    Falini, B.8    Delsol, G.9    Lemke, H.10    Schwarting, R.11    Lennert, K.12
  • 13
    • 0024333720 scopus 로고
    • The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's lymphoma using fixed frozen tissue
    • Agnarsson, B. A. and Kadin, M. E. (1989). The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's lymphoma using fixed frozen tissue. Cancer, 63, 2083-2087.
    • (1989) Cancer , vol.63 , pp. 2083-2087
    • Agnarsson, B.A.1    Kadin, M.E.2
  • 14
    • 7344233628 scopus 로고
    • Immunophenotypes of Reed-Sternberg cells: A study of 19 cases of Hodgkin's lymphoma in plastic-embedded sections
    • Casey, T. T., Olson, S. J., Cousar, J. B. and Collins, R. D. (1989). Immunophenotypes of Reed-Sternberg cells: a study of 19 cases of Hodgkin's lymphoma in plastic-embedded sections. Blood, 74, 5042-5046.
    • (1989) Blood , vol.74 , pp. 5042-5046
    • Casey, T.T.1    Olson, S.J.2    Cousar, J.B.3    Collins, R.D.4
  • 15
    • 0024400867 scopus 로고
    • Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's lymphoma are probable dendritic cell malignancies
    • Kennedy, I. C., Hart, D. N. and Colls, B. M. (1989). Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's lymphoma are probable dendritic cell malignancies. Clin. Exp. Immunol., 76, 324-331.
    • (1989) Clin. Exp. Immunol. , vol.76 , pp. 324-331
    • Kennedy, I.C.1    Hart, D.N.2    Colls, B.M.3
  • 16
    • 0027453460 scopus 로고
    • The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's lymphoma and contributes to the stimulating capacity of Hodgkin's lymphoma-derived cell lines
    • Delabie, J., Ceuppens, J. L., Vandenberghe, P., de Boer, M., Coorevits, L. and de Wolf-Peeters, C. (1993). The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's lymphoma and contributes to the stimulating capacity of Hodgkin's lymphoma-derived cell lines. Blood, 82, 2845-2852.
    • (1993) Blood , vol.82 , pp. 2845-2852
    • Delabie, J.1    Ceuppens, J.L.2    Vandenberghe, P.3    De Boer, M.4    Coorevits, L.5    De Wolf-Peeters, C.6
  • 17
    • 0027394657 scopus 로고
    • The IL-2/IL-2 receptor system: A current overview
    • Taniguchi, T. and Minami, Y. (1993). The IL-2/IL-2 receptor system: a current overview. Cell, 73, 5-8.
    • (1993) Cell , vol.73 , pp. 5-8
    • Taniguchi, T.1    Minami, Y.2
  • 18
    • 0028205130 scopus 로고
    • Recombinant single-chain immunotoxins against T- and B-cell leukemias
    • Kreitman, R. J. and Pastan, I. (1994). Recombinant single-chain immunotoxins against T- and B-cell leukemias. Leuk. Lymph., 13, 1-10.
    • (1994) Leuk. Lymph. , vol.13 , pp. 1-10
    • Kreitman, R.J.1    Pastan, I.2
  • 19
    • 0023128587 scopus 로고
    • IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases
    • Strauchen, J. A. and Breakstone, B. A. (1987). IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases. Am. J. Pathol., 126, 506-512.
    • (1987) Am. J. Pathol. , vol.126 , pp. 506-512
    • Strauchen, J.A.1    Breakstone, B.A.2
  • 20
    • 0023832767 scopus 로고
    • An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins
    • Till, M., May, R. D., Uhr, J. W., Thorpe, P. E. and Vitetta, E. S. (1988). An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins Cancer Res., 48, 1119-1123.
    • (1988) Cancer Res. , vol.48 , pp. 1119-1123
    • Till, M.1    May, R.D.2    Uhr, J.W.3    Thorpe, P.E.4    Vitetta, E.S.5
  • 23
    • 0025948173 scopus 로고
    • Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice
    • Engert, A., Martin, G., Amlot, P., Wijdenes, J., Diehl, V. and Thorpe, P. (1991). Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice. Int. J. Cancer, 49, 450-456.
    • (1991) Int. J. Cancer , vol.49 , pp. 450-456
    • Engert, A.1    Martin, G.2    Amlot, P.3    Wijdenes, J.4    Diehl, V.5    Thorpe, P.6
  • 24
    • 0028044582 scopus 로고
    • Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins
    • Winkler, U., Gottstein, C., Schön.,G., Kapp, U., Wolf, J., Hansmann, M. L., Bohlen, H., Thorpe, P., Diehl, V. and Engert, A. (1994). Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins Blood, 83, 466-475.
    • (1994) Blood , vol.83 , pp. 466-475
    • Winkler, U.1    Gottstein, C.2    Schön, G.3    Kapp, U.4    Wolf, J.5    Hansmann, M.L.6    Bohlen, H.7    Thorpe, P.8    Diehl, V.9    Engert, A.10
  • 30
    • 0027156735 scopus 로고
    • Immunotoxins: Magic bullets or misguided missiles?
    • Vitetta, E. S., Thorpe, P. E. and Uhr, J. W. (1993). Immunotoxins: magic bullets or misguided missiles? Immunol. Today, 14, 252-259.
    • (1993) Immunol. Today , vol.14 , pp. 252-259
    • Vitetta, E.S.1    Thorpe, P.E.2    Uhr, J.W.3
  • 31
    • 0026102692 scopus 로고
    • Rationale for clinical use of immunotoxins in cancer and autoimmune diseases
    • Byers, V. S. and Baldwin, R. W. (1991). Rationale for clinical use of immunotoxins in cancer and autoimmune diseases. Sem. Cell Biol., 2, 59-70.
    • (1991) Sem. Cell Biol. , vol.2 , pp. 59-70
    • Byers, V.S.1    Baldwin, R.W.2
  • 33
    • 0029665818 scopus 로고    scopus 로고
    • Metabolism of TAC (IL2Rα): Physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding
    • Junghans, R. P. and Waldmann, T. A. (1996). Metabolism of TAC (IL2Rα): Physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding. J. Exp. Med., 185, 1587-1602.
    • (1996) J. Exp. Med. , vol.185 , pp. 1587-1602
    • Junghans, R.P.1    Waldmann, T.A.2
  • 34
    • 0026806808 scopus 로고
    • Recombinant toxins containing the variable domains of the anti-TAC monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia
    • Kreitman, R. J., Chaudhary, V. K., Kozak, R. W., FitzGerald, D. J. P., Waldmann, T. A. and Pastan, I. (1992). Recombinant toxins containing the variable domains of the anti-TAC monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia. Blood, 80, 2344-2352.
    • (1992) Blood , vol.80 , pp. 2344-2352
    • Kreitman, R.J.1    Chaudhary, V.K.2    Kozak, R.W.3    FitzGerald, D.J.P.4    Waldmann, T.A.5    Pastan, I.6
  • 35
    • 0027223468 scopus 로고
    • Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or Diphteria toxin toward lymphocytes from patients with adult T-cell leukemia
    • Kreitman, R. J., Chaudhary, V. K., Waldmann, T. A., Hanchard, B., Cranston, B., FitzGerald, D. J. P. and Pastan, I. (1993). Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or Diphteria toxin toward lymphocytes from patients with adult T-cell leukemia. Leukemia, 7, 553-562.
    • (1993) Leukemia , vol.7 , pp. 553-562
    • Kreitman, R.J.1    Chaudhary, V.K.2    Waldmann, T.A.3    Hanchard, B.4    Cranston, B.5    FitzGerald, D.J.P.6    Pastan, I.7
  • 38
    • 0023529699 scopus 로고
    • Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein
    • Williams, D. P., Parker, K., Bacha, P., Bishai. W., Borowksi, M., Genbauffe, F., Strom, T. B. and Murphy, J. R. (1987). Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Prot Eng, 1. 493-498.
    • (1987) Prot Eng , vol.1 , pp. 493-498
    • Williams, D.P.1    Parker, K.2    Bacha, P.3    Bishai, W.4    Borowksi, M.5    Genbauffe, F.6    Strom, T.B.7    Murphy, J.R.8
  • 42
    • 0019981972 scopus 로고
    • Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's lymphoma and a subset of normal lymphoid cells
    • Schwab, U., Stein, H., Gerdes, J., Kirchner, H., Schaadt, M. and Diehl, V. (1982). Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's lymphoma and a subset of normal lymphoid cells. Nature, 299, 65-67.
    • (1982) Nature , vol.299 , pp. 65-67
    • Schwab, U.1    Stein, H.2    Gerdes, J.3    Kirchner, H.4    Schaadt, M.5    Diehl, V.6
  • 45
    • 0026587530 scopus 로고
    • Response of refractory Hodgkin's lymphoma to monoclonal anti-CD30 immunotoxin
    • Falini, B., Bolognesi, A., Flenghi, L., Tazzari, P. L., Broe, M. K., Stein, H. and Dürkop, H. (1992). Response of refractory Hodgkin's lymphoma to monoclonal anti-CD30 immunotoxin. Lancet, 339, 1195-1196.
    • (1992) Lancet , vol.339 , pp. 1195-1196
    • Falini, B.1    Bolognesi, A.2    Flenghi, L.3    Tazzari, P.L.4    Broe, M.K.5    Stein, H.6    Dürkop, H.7
  • 47
    • 0025122427 scopus 로고
    • Evaluation of ricin A-chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's lymphoma
    • Engert, A., Burrows, F., Jung, W., Tazzari, P. L., Stein, H., Pfreundschuh, M., Diehl, V. and Thorpe, P. (1990). Evaluation of ricin A-chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's lymphoma. Cancer Res., 50, 84-88.
    • (1990) Cancer Res. , vol.50 , pp. 84-88
    • Engert, A.1    Burrows, F.2    Jung, W.3    Tazzari, P.L.4    Stein, H.5    Pfreundschuh, M.6    Diehl, V.7    Thorpe, P.8
  • 48
    • 0025328975 scopus 로고
    • Antitumor effects of ricin A-chain immunotoxins prepared from intact antibodies and Fab′ fragments on solid human Hodgkin's lymphoma tumors in mice
    • Engert, A., Martin, G., Pfreundschuh, M., Amlot, P., Hsu, S. M., Diehl, V. and Thorpe, P. E. (1990). Antitumor effects of ricin A-chain immunotoxins prepared from intact antibodies and Fab′ fragments on solid human Hodgkin's lymphoma tumors in mice. Cancer Res., 50, 2929-2935.
    • (1990) Cancer Res. , vol.50 , pp. 2929-2935
    • Engert, A.1    Martin, G.2    Pfreundschuh, M.3    Amlot, P.4    Hsu, S.M.5    Diehl, V.6    Thorpe, P.E.7
  • 49
    • 0028908960 scopus 로고
    • Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4)
    • Horn-Lohrens, O., Tiemann, M., Lange, H., Koharg, J., Hafner, M., Hansen, H., Sterry, W., Parwaresch, R. M. and Lemke, H. (1995). Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4). In. J. Cancer, 60, 539-544.
    • (1995) In. J. Cancer , vol.60 , pp. 539-544
    • Horn-Lohrens, O.1    Tiemann, M.2    Lange, H.3    Koharg, J.4    Hafner, M.5    Hansen, H.6    Sterry, W.7    Parwaresch, R.M.8    Lemke, H.9
  • 50
    • 0028828078 scopus 로고
    • Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen
    • Schnell, R., Linnartz, C., Schön, G., Katouzi, A., Bohlen, H., Horn-Lohrens, O., Parwaresch, R., Diehl, V., Lemke, H. and Engert, A. (1995). Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen. Int. J. Cancer, 63, 238-244.
    • (1995) Int. J. Cancer , vol.63 , pp. 238-244
    • Schnell, R.1    Linnartz, C.2    Schön, G.3    Katouzi, A.4    Bohlen, H.5    Horn-Lohrens, O.6    Parwaresch, R.7    Diehl, V.8    Lemke, H.9    Engert, A.10
  • 51
    • 0028866012 scopus 로고
    • Cocktails of ricin A-chain immunotoxins against different antigens of Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in mice
    • Engert, A., Gottstein, C., Bohlen, H., Winkler, U., Schön. G., Manske, O., Schnell, R., Diehl, V. and Thorpe, P. (1995). Cocktails of ricin A-chain immunotoxins against different antigens of Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in mice. Int. J. Cancer, 63, 304-309.
    • (1995) Int. J. Cancer , vol.63 , pp. 304-309
    • Engert, A.1    Gottstein, C.2    Bohlen, H.3    Winkler, U.4    Schön, G.5    Manske, O.6    Schnell, R.7    Diehl, V.8    Thorpe, P.9
  • 52
    • 0023632524 scopus 로고
    • Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins
    • Katz, F. E., Janossy, G., Cumber, A., Ross, W., Blacklock, H. A., Tax, W. and Thorpe, P. E. (1987). Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins. Brit. J. Haemalot., 67, 407-411.
    • (1987) Brit. J. Haemalot. , vol.67 , pp. 407-411
    • Katz, F.E.1    Janossy, G.2    Cumber, A.3    Ross, W.4    Blacklock, H.A.5    Tax, W.6    Thorpe, P.E.7
  • 53
    • 0026803031 scopus 로고
    • The antitumor activity of an anti-CD 22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD 19 antibody or an anti-CD 19 immunotoxin
    • Ghetie, M. A., Tucker, K., Richardson, J., Uhr, J. W. and Vitetta, E. S. (1992). The antitumor activity of an anti-CD 22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD 19 antibody or an anti-CD 19 immunotoxin. Blood, 80, 2315-2320.
    • (1992) Blood , vol.80 , pp. 2315-2320
    • Ghetie, M.A.1    Tucker, K.2    Richardson, J.3    Uhr, J.W.4    Vitetta, E.S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.